1. Home
  2. FTEL vs ADTX Comparison

FTEL vs ADTX Comparison

Compare FTEL & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fitell Corporation

FTEL

Fitell Corporation

HOLD

Current Price

$0.43

Market Cap

1.7M

Sector

N/A

ML Signal

HOLD

Logo Aditxt Inc.

ADTX

Aditxt Inc.

HOLD

Current Price

$0.85

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEL
ADTX
Founded
2007
2017
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
2.0M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
FTEL
ADTX
Price
$0.43
$0.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.4M
2.8M
Earning Date
11-17-2025
11-18-2025
Dividend Yield
49.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,200,138.00
$5,945.00
Revenue This Year
N/A
$15,768.94
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.42
N/A
52 Week Low
$0.40
$0.81
52 Week High
$187.68
$6,183.90

Technical Indicators

Market Signals
Indicator
FTEL
ADTX
Relative Strength Index (RSI) 32.85 34.87
Support Level $0.47 $0.81
Resistance Level $0.58 $0.97
Average True Range (ATR) 0.08 0.17
MACD 0.02 -0.01
Stochastic Oscillator 12.31 2.82

Price Performance

Historical Comparison
FTEL
ADTX

About FTEL Fitell Corporation

Fitell Corp conducts its primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiary, serving personal training studios and commercial gyms. Its product coverage includes four proprietary brands: Muscle Motion for strength-training equipment, Rapid Motion with a focus on commercial items, FleetX for cardio equipment, and Harison for cardio, strength, recovery, and conditioning products. The Company operates in one segment, trading gym equipment, and also provides licensing services and gym equipment to overseas gym studios. Majority of its business is conducted in Australia via its e-commerce platform and third-party sites, with maximum revenue earned from retail.

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

Share on Social Networks: